TC Biopharm (Holdings) Plc

TC Biopharm (Holdings) Plcverified

TCBP

Price:

$6.65

Market Cap:

$1.74M

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.[Read more]

Industry

Biotechnology

IPO Date

2022-02-11

Stock Exchange

NASDAQ

Ticker

TCBP

The PE Ratio as of September 2024 (TTM) for TC Biopharm (Holdings) Plc (TCBP) is -0.03

According to TC Biopharm (Holdings) Plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -109.92% compared to the average of 0.30 of the last 4 quarters.

TC Biopharm (Holdings) Plc (TCBP) Historical PE Ratio (quarterly & annually)

How has TCBP PE Ratio performed in the past?

The mean historical PE Ratio of TC Biopharm (Holdings) Plc over the last ten years is -2.88. The current -0.03 PE Ratio has changed 4.06% with respect to the historical average. Over the past ten years (40 quarters), TCBP's PE Ratio was at its highest in in the June 2023 quarter at 1.68. The PE Ratio was at its lowest in in the September 2020 quarter at -6.47.

Quarterly (TTM)
Annual

Average

-2.88

Median

-2.25

Minimum

-5.38

Maximum

-0.13

TC Biopharm (Holdings) Plc (TCBP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of TC Biopharm (Holdings) Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 7.91%

Maximum Annual PE Ratio = -0.13

Minimum Annual Increase = -92.17%

Minimum Annual PE Ratio = -5.38

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.13-92.17%
2022-1.67-26.10%
2021-2.25-58.12%
2020-5.387.91%

TC Biopharm (Holdings) Plc (TCBP) Average PE Ratio

How has TCBP PE Ratio performed in the past?

The current PE Ratio of TC Biopharm (Holdings) Plc (TCBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.35

5-year avg

-2.88

10-year avg

-2.88

TC Biopharm (Holdings) Plc (TCBP) PE Ratio vs. Peers

How is TCBP’s PE Ratio compared to its peers?

TC Biopharm (Holdings) Plc’s PE Ratio is greater than ZyVersa Therapeutics, Inc. (-0.09), greater than Palisade Bio, Inc. (-0.35), greater than Unicycive Therapeutics, Inc. (-0.51), greater than Apexigen, Inc. (-0.36), greater than Immix Biopharma, Inc. (-2.69), greater than Revelation Biosciences, Inc. (-0.09), greater than Zura Bio Limited (-10.27), greater than Phio Pharmaceuticals Corp. (-0.22), greater than TransCode Therapeutics, Inc. (-0.14), greater than SeaStar Medical Holding Corporation (-0.47), greater than Virios Therapeutics, Inc. (-0.98), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.63), greater than Quoin Pharmaceuticals, Ltd. (-0.35), greater than Allarity Therapeutics, Inc. (-2.70), greater than Kiromic BioPharma, Inc. (-0.12), greater than Virax Biolabs Group Limited (-1.03), greater than Biodexa Pharmaceuticals Plc (-0.05), greater than Blue Water Vaccines, Inc. (-0.17), less than PaxMedica, Inc. Common Stock (-0.00), less than Hillstream BioPharma, Inc. (-0.00),

Build a custom stock screener for TC Biopharm (Holdings) Plc (TCBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TC Biopharm (Holdings) Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TC Biopharm (Holdings) Plc (TCBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TC Biopharm (Holdings) Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is TC Biopharm (Holdings) Plc's PE Ratio?

How is the PE Ratio calculated for TC Biopharm (Holdings) Plc (TCBP)?

What is the highest PE Ratio for TC Biopharm (Holdings) Plc (TCBP)?

What is the 3-year average PE Ratio for TC Biopharm (Holdings) Plc (TCBP)?

What is the 5-year average PE Ratio for TC Biopharm (Holdings) Plc (TCBP)?

How does the current PE Ratio for TC Biopharm (Holdings) Plc (TCBP) compare to its historical average?